Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y C Cheng

Showing results (301-310 of 403) with videos related to

Pageof 41
Sort By:
Biochemical Pharmacology|January 20, 1994
Antiviral activity of 2',3'-dideoxy-beta-L-5-fluorocytidine (beta-L-FddC) and 2',3'-dideoxy-beta-L-cytidine (beta-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitroT S Lin, M Z Luo, M C Liu, et al.
Journal of Virology|September 1, 1987
Association of Epstein-Barr virus early antigen diffuse component and virus-specified DNA polymerase activityJ S Li, B S Zhou, G E Dutschman, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1990
Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotidesW Y Gao, R N Hanes, M A Vazquez-Padua, et al.
Journal of Gastroenterology and Hepatology|January 22, 2003
Animal models for the study of HBV infection and the evaluation of new anti-HBV strategiesF Zoulim, P Berthillon, F L E Guerhier, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1996
2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivoF Zoulim, E Dannaoui, C Borel, et al.
Molecular Pharmacology|July 1, 1981
Differential affinities of 5-(2-halogenovinyl)-2'-deoxyuridines for deoxythymidine kinases of various originsY C Cheng, G Dutschman, E De Clercq, et al.
Seminars in Oncology|June 1, 1985
Dose-related pharmacologic effects of high-dose ara-C and its self-potentiationR L Capizzi, J L Yang, J P Rathmell, et al.
Emergency Medicine Journal : EMJ|May 26, 2009
Retrosternal haematoma presenting as cardiac tamponade in a blunt trauma patientY-C Cheng, J-W Huang, W-C Lee, et al.
Journal of Medicinal Chemistry|August 1, 1986
Antitumor agents. 78. Inhibition of human DNA topoisomerase II by podophyllotoxin and alpha-peltatin analoguesL S Thurston, H Irie, S Tani, et al.
Journal of Medicinal Chemistry|September 25, 1997
Synthesis, anti-human immunodeficiency virus and anti-hepatitis B virus activities of novel oxaselenolane nucleosidesJ Du, S Surzhykov, J S Lin, et al.
Pageof 41

Showing results (301-310 of 403) with videos related to

Sort By:
Pageof 41
Biochemical Pharmacology|January 20, 1994
Antiviral activity of 2',3'-dideoxy-beta-L-5-fluorocytidine (beta-L-FddC) and 2',3'-dideoxy-beta-L-cytidine (beta-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitroT S Lin, M Z Luo, M C Liu, et al.
Journal of Virology|September 1, 1987
Association of Epstein-Barr virus early antigen diffuse component and virus-specified DNA polymerase activityJ S Li, B S Zhou, G E Dutschman, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1990
Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotidesW Y Gao, R N Hanes, M A Vazquez-Padua, et al.
Journal of Gastroenterology and Hepatology|January 22, 2003
Animal models for the study of HBV infection and the evaluation of new anti-HBV strategiesF Zoulim, P Berthillon, F L E Guerhier, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1996
2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivoF Zoulim, E Dannaoui, C Borel, et al.
Molecular Pharmacology|July 1, 1981
Differential affinities of 5-(2-halogenovinyl)-2'-deoxyuridines for deoxythymidine kinases of various originsY C Cheng, G Dutschman, E De Clercq, et al.
Seminars in Oncology|June 1, 1985
Dose-related pharmacologic effects of high-dose ara-C and its self-potentiationR L Capizzi, J L Yang, J P Rathmell, et al.
Emergency Medicine Journal : EMJ|May 26, 2009
Retrosternal haematoma presenting as cardiac tamponade in a blunt trauma patientY-C Cheng, J-W Huang, W-C Lee, et al.
Journal of Medicinal Chemistry|August 1, 1986
Antitumor agents. 78. Inhibition of human DNA topoisomerase II by podophyllotoxin and alpha-peltatin analoguesL S Thurston, H Irie, S Tani, et al.
Journal of Medicinal Chemistry|September 25, 1997
Synthesis, anti-human immunodeficiency virus and anti-hepatitis B virus activities of novel oxaselenolane nucleosidesJ Du, S Surzhykov, J S Lin, et al.
Pageof 41